Brief: Acurx Announces Publication Of Positive Phase 2a Clinical Trial Results Of Ibezapolstat For CDI In Clinical Infectious Diseases
07/02/2022 13:22
Feb 7 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX ANNOUNCES PUBLICATION OF POSITIVE PHASE 2A CLINICAL
TRIAL
RESULTS OF IBEZAPOLSTAT FOR CDI IN CLINICAL INFECTIOUS DISEASES
Source text for Eikon: ID:nPn44KKKKa
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program